| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
CLINICAL SCIENCE |
Hypertension Unit, Nephrology Department, Hospital 12 de Octubre, Madrid, Spain.
Correspondence to. Dr. Julián Segura, Hypertension Unit. Hospital 12 de Octubre., Av. Córdoba s/n, 28041 Madrid, Spain. Phone: 34-91-3908198; Fax: 34-91-3908035; E-mail: jsegurad{at}senefro.org
ABSTRACT. The existence of a significant percentage of treated hypertensive patients presenting a diminished renal function has been recently described. Mild renal function abnormalities are recognized as powerful predictors of cardiovascular morbidity and mortality. However, longitudinal data demonstrating this association are lacking. The objectives of this study have been analysis of the evolution of GFR, assessed as creatinine clearance (CrCl), during long-term follow-up of hypertensive patients and evaluation of the impact of the development of chronic kidney disease (CKD) on cardiovascular prognosis. A historical cohort of 281 patients attending our Hypertension Unit was selected according to the following criteria: essential hypertension, more than 5 yr of follow-up, and normal GFR at baseline (CrCl > 90 ml/min per 1.73 m2). Patients had an average follow-up of 13.2 ± 4.8 yr. Forty-one patients (14.6%) developed CKD (CrCl < 60 ml/min per 1.73 m2) attributed to hypertensive nephrosclerosis. Initial serum creatinine, age, systolic BP at baseline, and average total cholesterol during follow-up were independent predictors of CKD development. Forty-nine (17.4%) of 281 patients presented a cardiovascular event during follow-up: 17 patients (40.6%) who developed CKD and 32 patients (13.3%) with preserved renal function (log rank test P < 0.001). After adjustment in a Cox multivariate analysis, age, development of CKD during follow-up, and male gender were independent predictors of the appearance of cardiovascular events. In essential hypertensive patients with normal renal function at baseline, the development of CKD during the follow-up is strongly and independently related with poor cardiovascular prognosis.
This article has been cited by other articles:
![]() |
N. Thilly, S. Boini, M. Kessler, S. Briancon, and L. Frimat Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale) Nephrol. Dial. Transplant., November 11, 2008; (2008) gfn566v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Rifkin, M. G. Shlipak, R. Katz, L. F. Fried, D. Siscovick, M. Chonchol, A. B. Newman, and M. J. Sarnak Rapid Kidney Function Decline and Mortality Risk in Older Adults Arch Intern Med, November 10, 2008; 168(20): 2212 - 2218. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Elsayed, H. Tighiouart, J. Griffith, T. Kurth, A. S. Levey, D. Salem, M. J. Sarnak, and D. E. Weiner Cardiovascular Disease and Subsequent Kidney Disease Arch Intern Med, June 11, 2007; 167(11): 1130 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Ruilope and J. Segura Blood pressure lowering or selection of antihypertensive agent: which is more important? Nephrol. Dial. Transplant., April 1, 2006; 21(4): 843 - 845. [Full Text] [PDF] |
||||
![]() |
J. Segura, J. A. Garcia-Donaire, M. Praga, and L. M. Ruilope Chronic Kidney Disease as a Situation of High Added Risk in Hypertensive Patients J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S136 - S140. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J Epstein and J. G Gums Angiotensin Receptor Blockers versus ACE Inhibitors: Prevention of Death and Myocardial Infarction in High-Risk Populations Ann. Pharmacother., March 1, 2005; 39(3): 470 - 480. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673